<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dicerna Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The Company is using its proprietary GalXC RNAi technology platform to build a broad pipeline in these therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $188,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas M. Fambrough, III, Ph.D.
    • FOUNDED
      2007
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    ProQR Therapeutics N.V.

    ProQR Therapeutics N.V.

    We are ProQR, a company on a mission to create new medicines for patients in need....

    We are ProQR, a company on a mission to create ...

    Filing Type:    PU
    Vericel Corporation

    Vericel Corporation

    Vericel is a leader in advanced therapies for the sports medicine and severe burn ...

    Vericel is a leader in advanced therapies for t...

    Filing Type:    PU
    BiondVax Pharmaceuticals Ltd.

    BiondVax Pharmaceuticals Ltd.

    BiondVax is an innovative biopharmaceutical company developing a universal flu vac...

    BiondVax is an innovative biopharmaceutical com...

    Filing Type:    PU
    Soleno Therapeutics, Inc.

    Soleno Therapeutics, Inc.

    Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercializa...

    Soleno Therapeutics, Inc. (Soleno) is focused o...

    Filing Type:    PU
    Bellerophon Therapeutics, Inc.

    Bellerophon Therapeutics, Inc.

    At Bellerophon Therapeutics, we aim to transform the lives of people suffering fro...

    At Bellerophon Therapeutics, we aim to transfor...

    Filing Type:    PU
    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc. is a leading regenerative medicine company focused on ...

    Organogenesis Holdings Inc. is a leading regene...

    Filing Type:    PU
    Intercept Pharmaceuticals, Inc.

    Intercept Pharmaceuticals, Inc.

    Intercept is a biopharmaceutical company focused on the development and commercial...

    Intercept is a biopharmaceutical company focuse...

    Filing Type:    PU
    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical‑stage biopharmaceutical c...

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a c...

    Filing Type:    PU
    Tiziana Life Sciences plc

    Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biot...

    Tiziana Life Sciences is a dual-listed (NASDAQ:...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc.

    We are a patient-centric, clinical-stage biopharmaceutical company dedicated to br...

    We are a patient-centric, clinical-stage biopha...

    Filing Type:    PU
    Athersys, Inc.

    Athersys, Inc.

    We are an international biotechnology company that is focused in the field of rege...

    We are an international biotechnology company t...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.